id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0237-0043,FDA,FDA-2006-N-0237,Request for Extension from Pendergast Consulting,Other,Request for Extension,2008-12-11T05:00:00Z,2008,12,2008-12-11T05:00:00Z,,2016-02-05T18:52:44Z,,0,0,0900006480456b9a
FDA-2006-N-0237-0044,FDA,FDA-2006-N-0237,Attachment A Comments in Response to the Food and Drug Administration Notices of Proposed Rulemaking Response of America's Health Insurance Plans re Comment from America's Health Insurance Plans (AHIP),Supporting & Related Material,Background Material,2008-12-11T05:00:00Z,2008,12,,,2016-02-05T18:31:42Z,,0,0,0900006480456c00
FDA-2006-N-0237-0042,FDA,FDA-2006-N-0237,Request for Extension from Public Citizen,Other,Request for Extension,2008-12-11T05:00:00Z,2008,12,2008-12-11T05:00:00Z,,2016-02-09T19:04:57Z,,0,0,0900006480456b95
FDA-2006-N-0237-0013,FDA,FDA-2006-N-0237,Reference 1 OMB Review re Comment from HF-26,Supporting & Related Material,Reference (internal unless indicated),2008-10-10T04:00:00Z,2008,10,,,2016-02-05T20:28:17Z,,0,0,0900006480456b67
FDA-2006-N-0237-0012,FDA,FDA-2006-N-0237,Cancer Leadership Council (CLC) to the FDA - Letter,Other,LET-Letter,2008-10-10T04:00:00Z,2008,10,2008-10-10T04:00:00Z,,2013-07-28T01:56:37Z,,0,0,09000064807444fd